Vyepti Financial Assistance Guide

GUIDES

In 2018, a new class of medications was approved by the FDA for the prevention of migraine in adults. These drugs are referred to as calcitonin gene-related peptide (CGRP) inhibitors. There are currently multiple CGRP medications on the market. Dosing, frequency of use and method of action vary.
 
The financial assistance guide below is for anyone who has been prescribed Vyepti by their healthcare provider. Vyepti is one of three new CGRP inhibitors approved for the prevention of migraine in adults. If you or someone you know requires help with paying for treatment, review the details provided below to see if you qualify for the manufacturer’s financial assistance programs.

Most insurance companies have added at least one or two of these CGRP inhibitors to the list of medicines they cover; however, patients still struggle to receive insurance approval for the prescribed CGRP inhibitor. Each pharmaceutical company is offering financial assistance programs to help cover and/or to help cover the cost of high copays. Each program is different and various programs exist to support patients with private, government-funded insurance, as well as the uninsured.

To help patients understand each program, CHAMP created Financial Assistance Guides for the three CGRP inhibitors. These guides are not produced or approved by the medication manufacturers. CHAMP is not endorsing the use of any CGRP inhibitor over another, nor promoting the use of this new class of preventive medications for everyone with migraine disease. Every patient needs to consult their healthcare provider to determine if CGRP inhibitors are right for you.

I Have Been Prescribed Vyepti. What Financial Assistance Programs Exists To Help Me?

Find your insurance coverage and see what Financial Assistance Programs exist to help.

I Have a Private/Commercial Insurance Plan
This category includes insurance plans provided through an employer, purchased with subsidy support from the Affordable Care Act (Obamacare) or purchased privately.
 

Highlights of Vyepti Copay Assistance Program

If you are 17 years or older, your health plan covers Vyepti and your health plan is a commercial plan, you could pay $5 per infusion, up to a $4,000 annual cap. This applies to your out-of-pocket costs, for the product, including co-insurance and copayments for Vyepti. You are responsible for costs above the $4,000 annual maximum. You should confirm your out-of-pocket cost with your physician or specialty pharmacy.
 
Offer will automatically renew each calendar year. If you no longer wish to participate in the program, please call 1-833-4-VYEPTI to cancel anytime.
 

Steps to Receive Co-Pay Assist Savings Offer

  1. Confirm with your healthcare provider or insurance provider that Vyepti is covered by your commercial health insurance plan.
  2. Confirm eligibility and enroll in the Vyepti Copay Assistance Program over the phone at 1-833-4-VYEPTI. Online enrollment available at vyepti.com/savings-and-support/copay
  3. Receive Vyepti Copay Assistance Program information at the time of enrollment (if eligible). This information will also be included in the Welcome Letter that you receive in the mail. Your physician will also receive a copy of your VYEPTI Copay Assistance Program information.

Congratulations on accessing your first dose of Vyepti! Lundbeck will work behind the scenes to get your doctor to complete a prior authorization form and to get your insurance company to cover your Vyepti prescription. Contact your doctor’s office to see if they have completed the Vyepti prior authorization form. Contact your insurance company to see if they will cover your prescribed medicine. If you have questions or encounter problems, contact the helpline at 1-833-4-VYEPTI.

I Have Medicare, Medicaid or other Government Insurance Plan

The Vyepti Copay Assistance Program is not available to patients whose medical insurance is provided by state or federal programs, like Medicare and Medicaid. This restriction is true for all CGRP inhibitor medications.

The Federal Government does not allow people who are receiving insurance benefits through Medicare, Medicaid, etc. to use co-pay assistance, discount or savings cards offered by pharmaceutical companies. The intent is to steer patients to lower-cost generic drugs and not to support higher-cost brand-name drugs. Unfortunately, there are no generic/biosimilar medications in the class of CGRP inhibitors and won’t be for years to come.

I Am Uninsured

The Vyepti Copay Assistance Program is not available to patients who are uninsured.

Uninsured patients or those without insurance coverage for Vypeti can find more information about Lundbeck Migraine Patient Assistance Program by calling the Support Center at 877-288-9125 or on the Lundbeck website at lundbeck.com/us/our-commitment/patient-assistance. The support center will assess each patient on a case-by-case basis to determine whether he or she meets the program’s eligibility criteria.

Where do I turn if I am not eligible for a financial assistance program?

The Patient Advocate Foundation (a CHAMP participant organization) can be a helpful resource for patients and caregivers who are experiencing access challenges. PAF provides a suite of expert tips to help navigate insurance denials, appeals and common barriers at: patientadvocate.org/migrainematters.

PAF also offers one-on-one case management assistance through its dedicated Migraine Careline for people living with migraine who experience access challenges. The Migraine Careline provides assistance with: navigating eligibility and enrollment in disability benefits; overcoming insurance coverage; and financial burdens that impact patient access to care.

All services are completely free and provided through phone and/or email communication. Visit migraine.pafcareline.org or call 866-688-3625 to speak with a case manager today.

Vyepti Basics

  • Brand Name

  • Vyepti
  • Biologic Name

  • eptinezumab-jjmr
  • Pharmaceutical Company

  • Lundbeck Seattle Bio Pharmaceuticals
  • Additional Help Available

  • Vyepti Go – a personalized support program to help patients through the Vyepti treatment journey.
  • Dosing & Administration

  • 100 mg as an intravenous infusion over approximately 30 minutes every 3 months. Some patients may benefit from a dosage of 300 mg. Your doctor will determine which option is best for you.
  • Indication

  • Preventive treatment of migraine in adults.

  • Home Delivery Available

  • Yes, Vyepti can be administered through a Home Healthcare provider.  Home Infusion/Home Health agencies can obtain VYEPTI from the authorized distribution network.

Join the CHAMP community